Cargando…
Patient profiling in diabetes and role of canagliflozin
BACKGROUND: Physicians attempt to achieve glycemic goals in patients with type 2 diabetes mellitus (T2DM) through various means, including glucose-lowering medications. There is interindividual variability in response to medications, which can be partially explained by the presence of genetic polymo...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270036/ https://www.ncbi.nlm.nih.gov/pubmed/25540592 http://dx.doi.org/10.2147/52761.S0 |